• Approval

Eisai Submits Application in Europe Seeking Approval for Fycompa as Treatment for Pediatric Patients With Epilepsy

New Delhi, Febraury 14, 2019:  Eisai Co., Ltd. announced today that it has submitted an application to the European Medicines Agency…